Current filters:

HealthcareMerck KGaA

Merck Serono’s Erbitux to be funded by CDF in England for mCRC


The UK’s Cancer Drugs Fund (CDF) says that Erbitux (cetuximab) can be used in the first line setting…

ErbituxFinancialHealthcareMerck KGaAMerck SeronoNorthern EuropeOncologyPharmaceuticalUK

Merck KGaA launches donation program for praziquantel in Sudan


German health care and chemicals firm Merck KGaA (MRK: DE) has donated six million praziquantel tablets…

Antibiotics and Infectious diseasesHealthcareMerck KGaAPharmaceuticalpraziquantelRest of the World

Big Pharma doing more for access to medicine in developing countries than two years ago


The latest Access to Medicine Index, which ranks the top 20 pharmaceutical companies on their efforts…

AstraZenecaBayerGlaxoSmithKlineGlobalHealthcareJohnson & JohnsonMerck KGaAPharmaceuticalPricingResearch

One cheer for Pfizer’s Fablyn


Pfizer’s osteoporosis drug Fablyn (lasofoxifene), being developed jointly with Ligand Pharmaceuticals…

Alendronate SodiumBonivaEvistaFosamaxGenericsGlobalHealthcareIbandronate SodiumLillyMerck KGaANovartisPfizerPharmaceuticalRaloxifeneReclastRocheZoledronic Acid Injection

US drug giants joint forces to speed lung and gastric cancer research in Asia


With the aim of accelerating research and improve treatment for lung and gastric cancer in Asia, three…

Asia-PacificDrug DiscoveryHealthcareLillyMerck KGaAOncologyPfizerPharmaceutical

US health spending estimated at $2,500 billion and 17.3% of GDP In 2009


In the wake of apparently stalled American health care reform, according to annual government projections…

HealthcareMerck KGaANorth AmericaPfizerPharmaceuticalPricing

“Extraordinary” drug price hikes identified by USA’s GAO


A study from the USA’s General Accountability Office, the investigational body of Congress, has…

GeneralHealthcareMerck KGaANorth AmericaPfizerPharmaceuticalPoliticsPricing

Back to top